13 June 2023: Clinical Research
Comparison of Texture and Color Enhancement Imaging with White Light Imaging in 52 Patients with Short-Segment Barrett’s Esophagus
Atsushi Ikeda 1BCDEF , Tsutomu Takeda 1ABCDEFG* , Hiroya Ueyama 1BCE , Yasuko Uemura 1B , Tomoyo Iwano 1B , Momoko Yamamoto 1B , Ryouta Uchida 1B , Hisanori Utsunomiya 1B , Shotaro Oki 1B , Nobuyuki Suzuki 1B , Daiki Abe 1B , Noboru Yatagai 1B , Yoichi Akazawa 1B , Kumiko Ueda 1D , Daisuke Asaoka 1D , Tomoyoshi Shibuya 1D , Mariko Hojo 1D , Shuko Nojiri 2C , Akihito Nagahara 1ACDEFGDOI: 10.12659/MSM.940249
Med Sci Monit 2023; 29:e940249
Table 1 Characteristics and endoscopic findings for all 52 patients.
| Characteristics | Value |
|---|---|
| Sex (males/females) | 25/27 |
| Age in years, mean±SD (range) | 64.1±14.2 (33–86) |
| Prague classification | C0M1: 34, C0M2: 4, C1M1: 7C1M2: 2, C2M2: 3, C2M3: 2 |
| Hiatus hernia (±) | 15/37 |
| Reflux esophagitis (±) | 16(LA-M/A/B: 3/10/3)/36 |
| Anti-acid therapy (±) | 24(PPI/PCAB/H2blocker: 15/8/1)/28 |
| Atrophic gastritis (±) | 29(C-1,2,3/O-1,2,3: 16/13)/23 |
| infection status | negative: 23, positive: 5, post-eradication: 24 |
| SD – standard deviation; LA – Los Angeles classification; PPI – proton pump inhibitor; PCAB – potassium competitive acid blocker; H2blocker – H2-receptor antagonist; – | |